Laroche Daniel, Grodecki Brian, Grimes Kara Rickford, Ng Chester
Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai Icahn School of Medicine, New York, NY, United States.
Department of Ophthalmology, Advanced Eyecare of New York, New York, NY, United States.
Front Ophthalmol (Lausanne). 2025 Feb 25;5:1408897. doi: 10.3389/fopht.2025.1408897. eCollection 2025.
The Ahmed FP-7 valve is useful in the management of refractory glaucoma. However, this can often have ocular hypertensive phase and subconjunctival fibrosis that can lead to increased medication use and failure. We report how retrobulbar and intraconal plate placement with tube extension can avoid the ocular hypertensive phase, lower intraocular pressure, and reduce medication burden.
This is a retrospective case series of 4 patients with glaucoma who underwent Ahmed FP-7 valve and retrobulbar/intraconal tube placement with a one-year follow-up.
One-year results in 4 patients with advanced glaucoma and pseudophakia revealed a pre-operative intraocular pressure of 21 mmHg on 5.5 medications. At one year, the post-operative intraocular pressure was 10.25 on 0 medications. The vision and visual fields were stable. One patient required drainage of a choroidal effusion and one patient required burping of viscoelastic on post-operative day one.
The combined insertion of the Ahmed FP-7 valve and silicone tube inserted into the retrobulbar/intraconal space has been shown to prevent ocular hypertensive phase, lower intraocular pressure, and reduce medication burden at one year.
艾哈迈德FP - 7瓣膜在难治性青光眼的治疗中很有用。然而，这种治疗常常会出现眼压升高期和结膜下纤维化，进而导致用药增加和治疗失败。我们报告了通过球后和肌锥内植入带延长管的瓣膜如何避免眼压升高期、降低眼压并减轻用药负担。
这是一项回顾性病例系列研究，对4例青光眼患者进行了艾哈迈德FP - 7瓣膜植入及球后/肌锥内管植入，并进行了为期一年的随访。
4例晚期青光眼和假晶状体患者的一年随访结果显示，术前眼压为21 mmHg，使用5.5种药物。一年后，术后眼压为10.25，未使用药物。视力和视野稳定。1例患者在术后第1天需要引流脉络膜积液，1例患者需要排出粘弹剂。
已证明，联合植入艾哈迈德FP - 7瓣膜和插入球后/肌锥内间隙的硅胶管可预防眼压升高期，降低眼压，并在一年时减轻用药负担。
